First chlamydia vaccine to reach Phase I trial appears safe and immunogenic
The first chlamydia vaccine to reach Phase I clinical trials has been observed to be safe and immunogenic in 35 women.
Browsing: Vaccines
Infectious disease and society: communicating scientific understanding to a suspicious audience
The manipulation of public opinion against lifesaving medicine and scientific facts is becoming an increasingly dangerous problem, but what can the science community do to convince people of the truth?
Respiratory syncytial virus: experimental structure-based vaccine candidate shows promise in Phase I trial
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
US FDA approves RECARBRIO™ for complicated UTIs and complicated intra-abdominal infections: July’s industry headlines
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
MERS vaccine safe and immunogenic in first-in-human trial
A DNA vaccine for MERS-CoV was demonstrated to be well-tolerated and immunogenic in a Phase I, first-in-human trial.
20 million children missed out on crucial vaccines in 2018
New research has revealed a dangerous stagnation in the global vaccination rates of children, owing to inequality, conflict and complacency.
Funding received for first Phase III trial of a chikungunya vaccine: June’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for Zebraxa, new…
Could widespread HPV vaccination eliminate cervical cancer?
A new meta-analysis including data from 60 million individuals over 8 years has demonstrated significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions following HPV vaccination in girls.
Neutralizing antibody shows promise for norovirus vaccine
New study determines a neutralizing antibody which binds to the most pandemic strain of norovirus in humans that could be utilized for an effective vaccine.
What influence could genetics have on immunity following vaccination?
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
